Endocrine Practice

Displaying 1 - 7 of 7
Schiazza, A. R., McManus, C., Hsu, S., Kuo, E., Lee, J., & Kuo, J. H. (2024). Radiofrequency Ablation of Toxic Thyroid Nodules: An Early Experience of a Single Institution in the United States. Endocrine Practice. https://doi.org/10.1016/j.eprac.2024.12.006
Publication Date
Tabatabai, L., Cosman, F., Curtis, J. R., DeSapri, K. T., LaBaume, C. T., Reginster, J.-Y., Rizzoli, R., Cortet, B., Wang, Y., Chiodo, J., & Mitlak, B. H. (2024). Comparative Effectiveness of Abaloparatide and Teriparatide in Women 50 Years of Age and Older: Update of a Real-World Retrospective Analysis. Endocrine Practice. https://doi.org/10.1016/j.eprac.2024.10.017
Publication Date
Rubin, M. R., Cusano, N., Yin, S., Tokareva, E., Ayodele, O., & Finkelman, R. D. (2024). Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism. Endocrine Practice, 30(3), 200–208. https://doi.org/10.1016/j.eprac.2023.12.001
Publication Date
McClung, M. R., Betah, D., Deignan, C., Shi, Y., Timoshanko, J., & Cosman, F. (2023). Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk. Endocrine Practice, 29(9), 716–722. https://doi.org/10.1016/j.eprac.2023.06.011
Publication Date
Gavigan, C., Abbey, E. J., McGready, J., Simonsick, E. M., & Mammen, J. S. (2023). Levothyroxine Dosing in Older Adults: Recommendations Derived From The Baltimore Longitudinal Study of Aging. Endocrine Practice, 29(8), 612–617. https://doi.org/10.1016/j.eprac.2023.05.002
Publication Date
Page-Wilson, G., Oak, B., Maguire, A., Silber, A., Okeyo, J., Ortiz, N., O’Hara, M., Moloney, S., & Geer, E. (2022). Abstract #1173493: Patient-reported Burden of Illness in Endogenous Cushing’s Syndrome. Endocrine Practice, 28(5), S109. https://doi.org/10.1016/j.eprac.2022.03.259
Publication Date